A molecular dynamics approach on the Y393C variant of protein disulfide isomerase A1.
Pablo A Madero-AyalaRosa E Mares-AlejandreMarco A Ramos-IbarraPublished in: Chemical biology & drug design (2020)
Human protein disulfide isomerase A1 (PDIA1) shows both catalytic (i.e., oxidoreductase) and non-catalytic (i.e., chaperone) activities and plays a crucial role in the oxidative folding of proteins within the endoplasmic reticulum. PDIA1 dysregulation is a common trait in numerous pathophysiological conditions, including neurodegenerative disorders and cancerous diseases. The 1178A>G mutation of the human PDIA1-encoding gene is a non-synonymous single nucleotide polymorphism detected in patients with Cole-Carpenter syndrome type 1 (CSS1), a particularly rare bone disease. In vitro studies showed that the encoded variant (PDIA1 Y393C) exhibits limited oxidoreductase activity. To gain knowledge on the structure-function relationship, we undertook a molecular dynamics (MD) approach to examine the structural stability of PDIA1 Y393C. Results showed that significant conformational changes are the structural consequence of the amino acid substitution Tyr>Cys at position 393 of the PDIA1 protein. This structure-based study provides further knowledge about the molecular origin of CCS1.
Keyphrases
- molecular dynamics
- amino acid
- endoplasmic reticulum
- density functional theory
- endothelial cells
- healthcare
- protein protein
- induced pluripotent stem cells
- genome wide
- pluripotent stem cells
- binding protein
- single molecule
- bone mineral density
- molecular dynamics simulations
- copy number
- heat shock protein
- oxidative stress
- dna methylation
- postmenopausal women
- gene expression
- bone regeneration